These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 16515773

  • 1. Rifampicin attenuates the MPTP-induced neurotoxicity in mouse brain.
    Oida Y, Kitaichi K, Nakayama H, Ito Y, Fujimoto Y, Shimazawa M, Nagai H, Hara H.
    Brain Res; 2006 Apr 12; 1082(1):196-204. PubMed ID: 16515773
    [Abstract] [Full Text] [Related]

  • 2. Neuroprotective effect of arundic acid, an astrocyte-modulating agent, in mouse brain against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity.
    Himeda T, Kadoguchi N, Kamiyama Y, Kato H, Maegawa H, Araki T.
    Neuropharmacology; 2006 Mar 12; 50(3):329-44. PubMed ID: 16303147
    [Abstract] [Full Text] [Related]

  • 3. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice.
    Kurosaki R, Muramatsu Y, Kato H, Watanabe Y, Imai Y, Itoyama Y, Araki T.
    Eur Neuropsychopharmacol; 2005 Jan 12; 15(1):57-67. PubMed ID: 15572274
    [Abstract] [Full Text] [Related]

  • 4. Protective effects of SUN N8075, a novel agent with antioxidant properties, in in vitro and in vivo models of Parkinson's disease.
    Oyagi A, Oida Y, Hara H, Izuta H, Shimazawa M, Matsunaga N, Adachi T, Hara H.
    Brain Res; 2008 Jun 12; 1214():169-76. PubMed ID: 18457816
    [Abstract] [Full Text] [Related]

  • 5. Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's disease.
    Meuer K, Pitzer C, Teismann P, Krüger C, Göricke B, Laage R, Lingor P, Peters K, Schlachetzki JC, Kobayashi K, Dietz GP, Weber D, Ferger B, Schäbitz WR, Bach A, Schulz JB, Bähr M, Schneider A, Weishaupt JH.
    J Neurochem; 2006 May 12; 97(3):675-86. PubMed ID: 16573658
    [Abstract] [Full Text] [Related]

  • 6. Evidence for a dissociation between MPTP toxicity and tyrosinase activity based on congenic mouse strain susceptibility.
    Hofele K, Sedelis M, Auburger GW, Morgan S, Huston JP, Schwarting RK.
    Exp Neurol; 2001 Mar 12; 168(1):116-22. PubMed ID: 11170726
    [Abstract] [Full Text] [Related]

  • 7. SEA0400, a specific Na+/Ca2+ exchange inhibitor, prevents dopaminergic neurotoxicity in an MPTP mouse model of Parkinson's disease.
    Ago Y, Kawasaki T, Nashida T, Ota Y, Cong Y, Kitamoto M, Takahashi T, Takuma K, Matsuda T.
    Neuropharmacology; 2011 Dec 12; 61(8):1441-51. PubMed ID: 21903118
    [Abstract] [Full Text] [Related]

  • 8. Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease.
    Liu LX, Chen WF, Xie JX, Wong MS.
    Neurosci Res; 2008 Feb 12; 60(2):156-61. PubMed ID: 18054104
    [Abstract] [Full Text] [Related]

  • 9. Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha.
    Sriram K, Miller DB, O'Callaghan JP.
    J Neurochem; 2006 Feb 12; 96(3):706-18. PubMed ID: 16405514
    [Abstract] [Full Text] [Related]

  • 10. A neuroprotective agent, T-817MA (1-{3-[2-(1-benzothiophen-5-yl)ethoxy]propyl} azetidin-3-ol maleate), prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice.
    Kawasaki T, Ago Y, Kitao T, Nashida T, Takagi A, Takuma K, Matsuda T.
    Neuropharmacology; 2008 Oct 12; 55(5):654-60. PubMed ID: 18573265
    [Abstract] [Full Text] [Related]

  • 11. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
    Muralikrishnan D, Samantaray S, Mohanakumar KP.
    Synapse; 2003 Oct 12; 50(1):7-13. PubMed ID: 12872288
    [Abstract] [Full Text] [Related]

  • 12. Neuroprotective effects of (+/-)-kavain in the MPTP mouse model of Parkinson's disease.
    Schmidt N, Ferger B.
    Synapse; 2001 Apr 12; 40(1):47-54. PubMed ID: 11170221
    [Abstract] [Full Text] [Related]

  • 13. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum.
    Kawasaki T, Ishihara K, Ago Y, Baba A, Matsuda T.
    J Pharmacol Exp Ther; 2007 Jul 12; 322(1):274-81. PubMed ID: 17429058
    [Abstract] [Full Text] [Related]

  • 14. Arundic acid, an astrocyte-modulating agent, protects dopaminergic neurons against MPTP neurotoxicity in mice.
    Kato H, Kurosaki R, Oki C, Araki T.
    Brain Res; 2004 Dec 24; 1030(1):66-73. PubMed ID: 15567338
    [Abstract] [Full Text] [Related]

  • 15. Riluzole (2-amino-6-trifluoromethoxy benzothiazole) attenuates MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice.
    Araki T, Muramatsu Y, Tanaka K, Matsubara M, Imai Y.
    Neurosci Lett; 2001 Oct 12; 312(1):50-4. PubMed ID: 11578843
    [Abstract] [Full Text] [Related]

  • 16. Fucoidan protects against dopaminergic neuron death in vivo and in vitro.
    Luo D, Zhang Q, Wang H, Cui Y, Sun Z, Yang J, Zheng Y, Jia J, Yu F, Wang X, Wang X.
    Eur J Pharmacol; 2009 Sep 01; 617(1-3):33-40. PubMed ID: 19545563
    [Abstract] [Full Text] [Related]

  • 17. Effects of blocking the dopamine biosynthesis and of neurotoxic dopamine depletion with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on voluntary wheel running in mice.
    Leng A, Mura A, Hengerer B, Feldon J, Ferger B.
    Behav Brain Res; 2004 Oct 05; 154(2):375-83. PubMed ID: 15313025
    [Abstract] [Full Text] [Related]

  • 18. Selective alterations of gene expression in mice induced by MPTP.
    Xu Z, Cawthon D, McCastlain KA, Slikker W, Ali SF.
    Synapse; 2005 Jan 05; 55(1):45-51. PubMed ID: 15499605
    [Abstract] [Full Text] [Related]

  • 19. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.
    D'Astous M, Morissette M, Tanguay B, Callier S, Di Paolo T.
    Synapse; 2003 Jan 05; 47(1):10-4. PubMed ID: 12422368
    [Abstract] [Full Text] [Related]

  • 20. Neuroprotective effect of riluzole in MPTP-treated mice.
    Araki T, Kumagai T, Tanaka K, Matsubara M, Kato H, Itoyama Y, Imai Y.
    Brain Res; 2001 Nov 09; 918(1-2):176-81. PubMed ID: 11684056
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.